HOME >> BIOLOGY >> NEWS
Northwest Branch Meeting of American Society for Microbiology, March 10-12 in Seattle

The University of Washington (UW) Department of Microbiology will host the American Society for Microbiology Northwest Branch Meeting for 2006. The Northwest Branch is comprised of microbiologists residing in Washington, Idaho, Montana, Oregon and British Columbia, Canada. ASM offers a wealth of resources to microbiologists including access to publications (12 journals and 5 others with specialized topic focus), education, awards and fellowships, mentoring programs, public policy guidelines and public education. The Northwest branch meeting will provide scientific and educational forums to interested students, faculty, and clinical microbiologists.

The meeting begins on Friday afternoon at 4 p.m., March 10 and concludes at noon, Sunday, March 12, 2006. All meetings will be held in the University of Washington Health Sciences Building. The attendees will be able to choose from 8 different sessions with more than 38 guest speakers, many who are pre-eminent in their fields. Friday evening, March 10, will feature keynote addresses by Dr. Stanley Maloy, San Diego State University and President of the American Society for Microbiology and Dr. Pete Greenberg, chair of the Department of Microbiology at the University of Washington. There will also be an opportunity for graduate students to present their research via presentation and poster sessions on Saturday.

The meeting is open to any and all interested persons. The registration fee is $20 for faculty and $10 for all others. The fee includes a catered reception on Friday evening and a box lunch on Saturday.

Speaker topics include:

  • Bacterial & viral pathogenesis
  • Physiology & gene regulation
  • Astrobiology & life in extreme environments
  • Genomics & computation microbiology
  • Microbial diversity & evolution
  • Clinical microbiology
  • New frontiers in microbial evolution

The schedule, maps, and so on are online at:

Contact: Dr. Steve Libby
slibby@u.washington.edu
University of Washington
24-Feb-2006


Page: 1 2

Related biology news :

1. Northwestern biologists demote Southeast Asias forest ox
2. Northwestern receives Gates Foundation grant for medical diagnostics
3. First wolverine radio-collared in Pacific Northwest
4. Northwest forest plan research and monitoring to be shared during 2-day conference
5. Northwestern and Chicago Botanic Garden join forces to train botanists
6. Illinois researchers presenting at ASPB Annual Meeting in Chicago, July 7-11
7. Meeting the ethanol challenge: Scientists use supercomputer to target cellulose bottleneck
8. Highlighted sessions of ASBMBs 2007 Annual Meeting
9. Award lectures for ASBMBs 2007 Annual Meeting
10. AACR to present distinguished public service awards at 2007 Annual Meeting
11. AACR Annual Meeting showcases significant developments in understanding and targeting cancers

Post Your Comments:
(Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ... Competitive Profiles - NEC" report to their offering. ... will continue to supply a range of IT security ... company focus on the development of a Big Data ... in the Asia-Pacific region is ...
(Date:4/8/2015)... , April 8, 2015  Infinisource, a ... and services, and Morpho, a leading supplier of ... to produce the market,s most advanced biometrically-enabled time ... iSolved NXG time clock is setting a bold, ... labor data for the small and mid-size employer. ...
(Date:4/2/2015)... 2, 2015 In the ... far outperforms the strongest competitors, showing outstanding performance ... the system is capable of a throughput of ... up to be ten times faster than most ... performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3
(Date:4/16/2015)... (PRWEB) April 16, 2015 Regis Technologies ... American Association for Cancer Research (AACR) annual meeting. Regis ... Convention Center, starting Saturday, April 18, in Philadelphia and ... claim to title of the oldest and largest organization ... fellowships and grants, and partners with survivors to promote ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 ... at Charlotte (UNC Charlotte) spin-out company, announced today ... Cooper, Ph.D., M.D., as Chief Operating Officer (COO). ... of experience in developing clinical diagnostic and biotechnology ... infectious disease. , Cooper’s extensive career transcends the ...
(Date:4/16/2015)... 16, 2015  In recognition of World Hemophilia Day, ... groups to illuminate more than 15 prominent landmarks red throughout ... Boston,s Zakim Bridge and Prudential Tower, ... Mercedes-Benz Superdome and Denver,s ... of April 17, and coincide with hemophilia community events in ...
(Date:4/16/2015)... April 16, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... U.S. joint venture with G-treeBNT (ReGenTree LLC) has ... clinical trial for the orphan disorder, neurotrophic keratopathy ... dry eye syndrome (DES) in the U.S.  Both ... RGN-259/GBT201, this year.  Each of these eye disorders ...
Breaking Biology Technology:Regis Technologies Joins American Association for Cancer Research Annual Meeting 2OncoTAb Names Dr. David L. Cooper as COO 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 3Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5
Cached News: